| 161 |
Survival outcomes of CD34+CD38−LSCs and their expression of
CD123 in adult AML patients |
2018 |
| 162 |
Synthetic lethality of PRMT5 inhibition in NDRG2-deficient adult T-cell leukemia through HSP90A dysfunction |
2018 |
| 163 |
The adipokine Chemerin and Fetuin-A Serum Levels in Type 2 Diabetes Mellitus: Relation to Obesity and Inflammatory Markers |
2018 |
| 164 |
The adipokine Chemerin and Fetuin-A Serum Levels in Type 2 Diabetes Mellitus: Relation to Obesity and Inflammatory Markers |
2018 |
| 165 |
The adipokine Chemerin and Fetuin-A Serum Levels in Type 2 Diabetes Mellitus: Relation to Obesity and Inflammatory Markers |
2018 |
| 166 |
The adipokine Chemerin and Fetuin-A Serum Levels in Type 2 Diabetes Mellitus: Relation to Obesity and Inflammatory Markers |
2018 |
| 167 |
the role hepatitis C and possiple risk factors in development of hepatocellular carcinoma :400 patients based study |
2018 |
| 168 |
Tissue Indices of Telomere Length and p53 in Patients with Different Gastrointestinal Tumors: Correlation with Clinicopathological Status
|
2018 |
| 169 |
Tissue Indices of Telomere Length and p53 in Patients with Different Gastrointestinal Tumors: Correlation with Clinicopathological Status
|
2018 |
| 170 |
Tissue Indices of Telomere Length and p53 in Patients with Different Gastrointestinal Tumors: Correlation with Clinicopathological Status
|
2018 |